Glyburide Tablet
Product Images NDC 0093-8342

4 FDA label images from Teva Pharmaceuticals Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 0093-8342). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Image 1
Chemical structure of glyburide, showing its molecular arrangement with aromatic rings, sulfonyl group, and other functional groups as part of the compound's design.*
FDA Label Image

Image 2

Image 2
Label for Glyburide Tablets USP 1.25 mg, a prescription oral tablet by Teva Pharmaceuticals USA, Inc. The label indicates a package size of 100 tablets, displays the NDC 0093-8342-01, and includes storage and dispensing instructions. It also notes the manufacturing origin as Zagreb, Croatia.*
FDA Label Image

Image 3

Image 3
Label for GlyBURIDE Tablets USP 2.5 mg oral tablets, containing 100 tablets per package. The label includes storage instructions, manufacturer details (Teva Pharmaceuticals USA, Inc.), and the NDC number 0093-8343-01. The label indicates the product is prescription only and features the Teva logo in red.*
FDA Label Image

Image 4

Image 4
Label for Glyburide Tablets USP 5 mg oral tablets by Teva Pharmaceuticals USA, Inc. The label indicates a package size of 100 tablets, NDC 0093-8344-01, with storage instructions at 20 to 25°C (68 to 77°F). It includes cautionary text on dispensing and child safety, and the product is prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.